Williams, Hywel C <br/><br/>
Surgery Versus 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma: 5-Year Results of the SINS Randomized Controlled Trial.  [electronic resource] 

 -  The Journal of investigative dermatology  03 2017 
 - 614-619 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1523-1747 
<br/><br/><label>Standard No.: </label>10.1016/j.jid.2016.10.019  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Topical<br/>Adolescent<br/>Adult<br/>Aged<br/>Aminoquinolines--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Basal Cell--drug therapy<br/>Child<br/>Female<br/>Humans<br/>Imiquimod<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local<br/>Skin Neoplasms--drug therapy<br/>Young Adult